ROYAL DAMES OF CANCER RESEARCH INC (EIN 591922210) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1969

Legal Domicile

Principal Officer

CHRISTINE REDMOND

Phone

9549460278

Tax Period

2023-01-01 to 2023-12-31

ROYAL DAMES OF CANCER RESEARCH INC, founded in 1969, is a small nonprofit in the Medical Research sector that reported $665K in total revenue in fiscal year 2023. Revenue decreased 10% compared to the prior year.

Mission

THE ORGANIZATION HELD FUND RAISING EVENTS TO GENERATE REVENUE TO BE USED IN MAKING CONTRIBUTIONS TO THE RUMBAUGH-GOODWIN INSTITUTE FOR CANCER RESEARCH. A GRANT OF 615,000 WAS MADE IN THE CURRENT YEAR.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $664,534

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $664,534

Expense Breakdown

Grants Paid $615,000

Salaries & Benefits $0

Fundraising Expenses $18,722

Program Expenses $615,000

Other Expenses $33,702

TOTAL EXPENSES $648,702

Year-over-Year Comparison

	2023	2022	Change
Revenue	$664,534	$735,799	-0.1%
Expenses	$648,702	$710,128	-0.1%
Net Income	$15,832	$25,671	-0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CAROLE NUGENT	PRESIDENT	32.00	Officer Director	$0	$0	$0
ILIANA IVANOVA	VP, WAYS AND	4.00	Officer Director	$0	$0	$0
KATINA PAESE	VP, MEMBERSH	8.00	Officer Director	$0	$0	$0
JAIME SHLIMBAUM	TREASURER	10.00	Officer Director	$0	$0	$0
JANE TONEY	RECORDING SE	5.00	Officer Director	$0	$0	$0
MARTHA BOHLER	CORRESPONDIN	8.00	Officer Director	$0	$0	$0
BONNIE BARNETT	TRUSTEE	4.00	Director	$0	$0	$0
CONNIE CHANEY	TRUSTEE	4.00	Director	$0	$0	$0
SHARON GUSTAFSON	TRUSTTEE	4.00	Director	$0	$0	$0
GLORIA JACARUSO	TRUSTEE	10.00	Director	$0	$0	$0
CAROL KALAGHER	TRUSTEE	4.00	Director	$0	$0	$0
MARY KAZARES	TRUSTEE	4.00	Director	$0	$0	$0
HELENA KOLENDA	TRUSTEE	4.00	Director	$0	$0	$0
ANITA KOTLER	TRUSTEE	4.00	Director	$0	$0	$0
ROBIN LOOF	TRUSTEE	4.00	Director	$0	$0	$0
NELL MCGUIRE	TRUSTEE	4.00	Director	$0	$0	$0
DR SHARON MCQUILLAN	TRUSTEE	4.00	Director	$0	$0	$0
VICTORIA MARTOCCIA	TRUSTEE	4.00	Director	$0	$0	$0
BONNIE MITTEN	TRUSTEE	4.00	Director	$0	$0	$0
SOPHIA MYLONA	TRUSTEE	10.00	Director	$0	$0	$0
LADAN PATEL	TRUSTEE	4.00	Director	$0	$0	$0
RHONDA RITCHIE	TRUSTEE	8.00	Director	$0	$0	$0
JOEY STOTSKY	TRUSTEE	4.00	Director	$0	$0	$0
NANCY WESTIN	TRUSTEE	4.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$664,534	$648,702	$32,396	$15,832
2022	$735,799	$710,128	$26,672	$25,671
2021	$416,094	$427,265	$1,001	$-11,171
2020	$121,211	$206,695	$12,172	$-85,484
2019	$403,003	$585,277	$97,656	$-182,274
2018	$268,712	$6,817	$279,930	$261,895

ROYAL DAMES OF CANCER RESEARCH INC